External Self-Closing Tube to Occlude a Vessel Gradually as a Therapeutic Means of Portosystemic Shunt
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, Tae Young | - |
dc.contributor.author | Kim, Dae-Hyun | - |
dc.contributor.author | Yoon, Jeong-Kee | - |
dc.contributor.author | Kim, Surim | - |
dc.contributor.author | Yi, Se Won | - |
dc.contributor.author | Oh, Won Taek | - |
dc.contributor.author | Park, Ju Young | - |
dc.contributor.author | Kim, Hye-Seon | - |
dc.contributor.author | Kang, Mi-Lan | - |
dc.contributor.author | Lee, Jung Bok | - |
dc.contributor.author | Sung, Hak-Joon | - |
dc.date.available | 2021-02-22T05:23:28Z | - |
dc.date.issued | 2020-08 | - |
dc.identifier.issn | 2366-3987 | - |
dc.identifier.uri | https://scholarworks.sookmyung.ac.kr/handle/2020.sw.sookmyung/1320 | - |
dc.description.abstract | The vascular network to the liver can be connected abnormally during fetal development (e.g., portosystemic shunt), thus requiring a device to close the flow connection completely. Gradual vascular occlusion is particularly important, because a sudden stop in blood flow can result in portal hypertension and cause consequential damage to the small intestine. Significant progress has been made in the development of such devices (e.g., the ameroid ring constrictor and cellophane banding) as a standard treatment for this disorder. However, incomplete occlusion is a common problem. In this study, a new vascular occlusion device is developed, enabling two major functions. First, user-friendly deployment onto the external vascular wall is achieved by programming a recovery in the shape of the tube from open to closed in response to treatment with a warm saline solution (37 degrees C). Second, proinflammatory palmitic acid is released over time from the tube surface through the adventitial wall to induce gradual occlusive vascular remodeling. These unprecedented functions are demonstrated in a series of experiments on cells and rabbit veins, addressing this major issue through gradual but complete vascular occlusion over time. The external self-closing tube represents a breakthrough proof-of-concept for treatment of this rare but critical developmental disorder. | - |
dc.format.extent | 7 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | Wiley Blackwell | - |
dc.title | External Self-Closing Tube to Occlude a Vessel Gradually as a Therapeutic Means of Portosystemic Shunt | - |
dc.type | Article | - |
dc.publisher.location | 미국 | - |
dc.identifier.doi | 10.1002/adtp.202000039 | - |
dc.identifier.scopusid | 2-s2.0-85103744591 | - |
dc.identifier.wosid | 000533255100001 | - |
dc.identifier.bibliographicCitation | Advanced Therapeutics, v.3, no.8, pp 1 - 7 | - |
dc.citation.title | Advanced Therapeutics | - |
dc.citation.volume | 3 | - |
dc.citation.number | 8 | - |
dc.citation.startPage | 1 | - |
dc.citation.endPage | 7 | - |
dc.type.docType | Article | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.relation.journalWebOfScienceCategory | Pharmacology & Pharmacy | - |
dc.subject.keywordPlus | AMEROID RING CONSTRICTORS | - |
dc.subject.keywordPlus | C-REACTIVE PROTEIN | - |
dc.subject.keywordPlus | DOGS | - |
dc.subject.keywordAuthor | external vascular wall | - |
dc.subject.keywordAuthor | portosystemic shunt | - |
dc.subject.keywordAuthor | proinflammation | - |
dc.subject.keywordAuthor | self-closing tubes | - |
dc.subject.keywordAuthor | vessel occlusion | - |
dc.identifier.url | https://onlinelibrary.wiley.com/doi/full/10.1002/adtp.202000039 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
Sookmyung Women's University. Cheongpa-ro 47-gil 100 (Cheongpa-dong 2ga), Yongsan-gu, Seoul, 04310, Korea02-710-9127
Copyright©Sookmyung Women's University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.